Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

1.16
-0.0399-3.32%
Post-market: 1.16-0.0001-0.01%16:00 EDT
Volume:14.54K
Turnover:17.02K
Market Cap:5.45M
PE:-0.68
High:1.20
Open:1.19
Low:1.15
Close:1.20
Loading ...

SciSparc Says Clearmind Medicine Files European Patent Application for Binge Behavior Psychedelic Combination Treatment

MT Newswires Live
·
06 Jan

BRIEF-Scisparc-Clearmind Medicine Collaboration Announces The Publication Of European Patent Application For Binge Behavior Psychedelic Combination Treatment

Reuters
·
06 Jan

Scisparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

THOMSON REUTERS
·
06 Jan

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

GlobeNewswire
·
06 Jan

Clearmind Medicine Says Macau Grants Patent for Binge Behavior Treatment; Shares Up Pre-Bell

MT Newswires Live
·
02 Jan

Clearmind Medicine granted patent for binge behavior treatment by Macau

TIPRANKS
·
02 Jan

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

THOMSON REUTERS
·
02 Jan

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

GlobeNewswire
·
02 Jan

Clearmind Medicine to move forward with MEAI-based alcohol substitute

TIPRANKS
·
26 Dec 2024

Clearmind Medicine Looks to Move Forward With Its Novel Psychedelic Meai- Based Alcohol Substitute

THOMSON REUTERS
·
26 Dec 2024

Top Midday Gainers

MT Newswires Live
·
25 Dec 2024

Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break

MT Newswires Live
·
24 Dec 2024

Clearmind Medicine Secures Institutional Review Board Approval for CMND-100's Phase 1/2a Trial in Alcohol Use Disorder; Shares Rise Pre-Bell

MT Newswires Live
·
24 Dec 2024

Clearmind Medicine receives IRB approval for Phase I/IIa trial of CMND-100

TIPRANKS
·
24 Dec 2024

Clearmind Medicine Receives Irb Approval for Its FDA-Regulated Clinical Trial

THOMSON REUTERS
·
24 Dec 2024

Clearmind, Dr Glitter sign term sheet for development of alcohol substitute

TIPRANKS
·
16 Dec 2024